SCHEMBL4934248

SCHEMBL4934248

CC(C)Nc1cc(COc2c(Br)cc(C(=O)NCC(=O)O)cc2Br)cc(C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 2/20 0.44
THRB P10828 2/20 0.44
TRPA1 O75762 2/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
RHOC P08134 1/20 0.38
RHOA P61586 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
MRGPRX4 Q96LA9 7/20 0.37
MME P08473 1/20 0.36
ACE P12821 1/20 0.36
CPA1 P15085 1/20 0.36
ACE2 Q9BYF1 1/20 0.36
ALDH1A1 P00352 1/20 0.35
TACR1 P25103 1/20 0.35
HTT P42858 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
PTPN1 P18031 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4931455 0.92 THRA (0.41) THRATHRBMEN1KMT2ARHOC
SCHEMBL5117735 0.90 THRA (0.44) THRATHRBMEN1KMT2ARHOC
SCHEMBL4923555 0.90 MRGPRX4 (0.41) TRPA1RHOCRHOAMRGPRX4
SCHEMBL4924564 0.90 THRA (0.45) THRATHRBMEN1KMT2ARHOC
SCHEMBL5111593 0.89 THRA (0.42) THRATHRBMEN1KMT2ARHOC
SCHEMBL4346172 0.88 THRA (0.47) THRATHRBTRPA1MEN1KMT2A
SCHEMBL5120143 0.87 THRA (0.42) THRATHRBMEN1KMT2ARHOC
SCHEMBL4930828 0.87 SMN1; SMN2 (0.39) THRATHRBMEN1KMT2ASMN1; SMN2
SCHEMBL5109507 0.86 THRA (0.42) THRATHRBMEN1KMT2ARHOC
SCHEMBL5106633 0.86 RHOC (0.43) THRATHRBTRPA1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA THRA 3/4885THRB 4/4885TRPA1 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.